| Accession |
PRJCA011601 |
| Title |
Phase Ib/II Clinical Study of LBL-007 in Treatment of Advanced Malignant Tumors |
| Relevance |
Medical |
| Data types |
Proteomic, Metabolome, Biomarker , etc.
|
| Organisms |
Homo sapiens
|
| Description |
(Trial No. LBL-007-CN-003) A Multicenter Phase Ib/II Clinical Study to Evaluate the Safety,Tolerability,and Efficacy of LBL-007 in Combination With Toripalimab in the Treatment of Advanced Malignancies |
| Sample scope |
Multiisolate |
| Release date |
2022-11-28 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| Nanjing Leads Biolabs Co.,Ltd.
|
|
LBL-007-CN-003
|
|
|
|
| Submitter |
Li
Zhang (zhangli@sysucc.org.cn)
|
| Organization |
Sun Yat-sen University Cancer Center |
| Submission date |
2022-09-01 |
